Immunomodulation in patients receiving intravenous bryostatin 1 in a phase I clinical study: Comparison with effects of bryostatin 1 on lymphocyte function in vitro.

C Scheid; J Prendiville; GC Jayson; D Crowther; B Fox; GR Pettit; PL. Stern

Immunomodulation in patients receiving intravenous bryostatin 1 in a phase I clinical study: Comparison with effects of bryostatin 1 on lymphocyte function in vitro.

C Scheid
, J Prendiville
, GC Jayson
, D Crowther
, B Fox
, GR Pettit
, PL. Stern

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1994
Journal	Cancer Immunology, Immunotherapy
Publication status	Published - 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{a88bd0d2ea124e2c95f166226c63e777,

title = "Immunomodulation in patients receiving intravenous bryostatin 1 in a phase I clinical study: Comparison with effects of bryostatin 1 on lymphocyte function in vitro.",

author = "C Scheid and J Prendiville and GC Jayson and D Crowther and B Fox and GR Pettit and PL. Stern",

year = "1994",

language = "English",

pages = "1994",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Immunomodulation in patients receiving intravenous bryostatin 1 in a phase I clinical study: Comparison with effects of bryostatin 1 on lymphocyte function in vitro.

AU - Scheid, C

AU - Prendiville, J

AU - Jayson, GC

AU - Crowther, D

AU - Fox, B

AU - Pettit, GR

AU - Stern, PL.

PY - 1994

Y1 - 1994

M3 - Article

SN - 0340-7004

SP - 1994

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -